Cancer Genome Interpreter Cancer Biomarkers database

Names

More detailed information about this field from each metasource. ×

Cancer Genome Interpreter Cancer Biomarkers database

metasource: BiŌkeanós-Medsourcing
version: 0.0.1:2022-11-04T13:34:25.975929

---

Cancer Biomarkers database

metasource: BiŌkeanós-Medsourcing
version: 0.0.1:2022-11-04T13:34:25.975929

Close

Other names: Cancer Biomarkers database

The Cancer Biomarkers database is curated and maintained by several clinical and scientific experts in the field of precision oncology. It contains information on genomic biomarkers (genes, including genomic coordinates of the variants in cDNA and gDNA) for cancer drugs and clinical targetability in solid tumors.

Webpage:

Licence:

Publications:

Publications

More detailed information about this field from each metasource. ×

Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors
PMID: 25656898

metasource: BiŌkeanós-Medsourcing
version: 0.0.1:2022-11-04T13:34:25.975929

---

https://doi.org/10.1101/140475

metasource: BiŌkeanós-Medsourcing
version: 0.0.1:2022-11-04T13:34:25.975929

Close

• Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors PubMed citations: 52.

  52 articles citing: Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors

  ×

  Going with the Flow: Modeling the Tumor Microenvironment Using Microfluidic Technology. PMID:34885161

  ---

  The Utility of Next-Generation Sequencing in the Treatment Decision-Making for Metastatic Non-Small-Cell Lung Cancer. PMID:34513491

  ---

  Molecular Pathology of Breast Tumors: Diagnostic and Actionable Genetic Alterations. PMID:34373096

  ---

  Advances in Tumor Sampling and Sequencing in Breast Cancer and their Application in Precision Diagnostics and Therapeutics. PMID:33983581

  ---

  Knowledge bases and software support for variant interpretation in precision oncology. PMID:33971666

  ---

  A New Insight for the Identification of Oncogenic Variants in Breast and Prostate Cancers in Diverse Human Populations, With a Focus on Latinos. PMID:33912047

  ---

  Bioinformatic analysis linking genomic defects to chemosensitivity and mechanism of action. PMID:33909629

  ---

  Next Generation Sequencing in Non-Small Cell Lung Cancer: Pitfalls and Opportunities. PMID:33333743

  ---

  Computational identification of biomarker genes for lung cancer considering treatment and non-treatment studies. PMID:33272232

  ---

  Linking Pharmacogenomic Information on Drug Safety and Efficacy with Ethnic Minority Populations. PMID:33113799

  ---

  Targeting TANK-binding kinase 1 (TBK1) in cancer. PMID:32962465

  ---

  Incorporating representation learning and multihead attention to improve biomedical cross-sentence n-ary relation extraction. PMID:32677883

  ---

  Evaluation of molecular subtypes and clonal selection during establishment of patient-derived tumor xenografts from gastric adenocarcinoma. PMID:32647357

  ---

  Collaborative, Multidisciplinary Evaluation of Cancer Variants Through Virtual Molecular Tumor Boards Informs Local Clinical Practices. PMID:32644817

  ---

  A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer. PMID:32246132

  ---

  OncoMX: A Knowledgebase for Exploring Cancer Biomarkers in the Context of Related Cancer and Healthy Data. PMID:32142370

  ---

  Development of a Precision Medicine Workflow in Hematological Cancers, Aalborg University Hospital, Denmark. PMID:32013121

  ---

  Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine Initiative. PMID:32002119

  ---

  Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients. PMID:31863614

  ---

  Challenges of Providing Concordant Interpretation of Somatic Variants in Non-Small Cell Lung Cancer: A Multicenter Study. PMID:31205538

  ---

  An unbiased in vitro screen for activating epidermal growth factor receptor mutations. PMID:30952700

  ---

  Database of evidence for precision oncology portal. PMID:30535306

  ---

  Next Generation Sequencing in Clinical Oncology: Applications, Challenges and Promises: A Review Article. PMID:30524974

  ---

  Variant information systems for precision oncology. PMID:30463544

  ---

  Afatinib treatment for her-2 amplified metastatic colorectal cancer based on patient-derived xenograft models and next generation sequencing. PMID:30307354

  ---

  Personalized therapy for lung cancer: striking a moving target. PMID:30089719

  ---

  Integrative omics analyses broaden treatment targets in human cancer. PMID:30053901

  ---

  Deep sequencing of human papillomavirus positive loco-regionally advanced oropharyngeal squamous cell carcinomas reveals novel mutational signature. PMID:29879932

  ---

  PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data. PMID:29848362

  ---

  Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations. PMID:29592813

  ---

  From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards. PMID:29544535

  ---

  Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions. PMID:29276046

  ---

  Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient Care. PMID:29241554

  ---

  Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach. PMID:29186355

  ---

  Next-generation Sequencing-based genomic profiling: Fostering innovation in cancer care? PMID:29160420

  ---

  Precision Oncology: The Road Ahead. PMID:28887051

  ---

  Tumor cells and their crosstalk with endothelial cells in 3D spheroids. PMID:28874803

  ---

  Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets. PMID:28804123

  ---

  Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies. PMID:28784769

  ---

  Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene. PMID:28618430

  ---

  mTCTScan: a comprehensive platform for annotation and prioritization of mutations affecting drug sensitivity in cancers. PMID:28482068

  ---

  Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance. PMID:28384287

  ---

  CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer. PMID:28138153

  ---

  Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers. PMID:27901097

  ---

  Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study. PMID:27765906

  ---

  Using Pharmacogenomic Databases for Discovering Patient-Target Genes and Small Molecule Candidates to Cancer Therapy. PMID:27746730

  ---

  Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples. PMID:27578032

  ---

  A network medicine approach to build a comprehensive atlas for the prognosis of human cancer. PMID:27559151

  ---

  Evaluation and consequences of heterogeneity in the circulating tumor cell compartment. PMID:26980749

  ---

  Precision medicine for cancer with next-generation functional diagnostics. PMID:26536825

  ---

  Drug repurposing in oncology--patient and health systems opportunities. PMID:26483297

  ---

  Advances in the Molecular Analysis of Soft Tissue Tumors and Clinical Implications. PMID:26297069
• https://doi.org/10.1101/140475